课题基金 / 基金详情

SEX HORMONES AND BODY FLUID REGULATION

SEX HORMONES AND BODY FLUID REGULATION
性激素和体液调节
批准号:
6638519
负责人:
NINA STACHENFELD
金额:
$27.44万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-01 至 2006-04-30

项目摘要

项目成果

NINA STACHENFELD的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) Estrogen and progesterone modulate body water and sodium at rest, and during perturbations of normal body fluid homeostasis, such as dehydration, hyponatremia and sodium loading. The mechanisms for these effects have been difficult to determine because estrogen and progesterone have opposing effects on body water and sodium regulation and increase concurrently in women of reproductive age. In the research design, the investigators temporarily inhibit sex steroid hormone secretion in young women with the gondotropin releasing-hormone analog, leuprolide acetate, and then isolate the effects of estrogen and progesterone on body water and sodium regulation by adding back each of these hormones. Leuprolide acetate down-regulates the hypothalamic-pituitary-ovarian axis with internalization of the GnRH receptors at the pituitary level. Following an initial stimulation, chronic administration of leuprolide acetate suppresses steroidogenes. After steroid hormone suppression, the investigators will "add back" natural estrogen and/or progesterone, in order to accomplish the following Specific Aims: 1) To determine effects of estrogen on the osmotic sensitivity of arginine vasopressin, and renal sensitivity to arginine vasopressin. Osmotically stimulated arginine vasopressin (AVP) increases during estrogen administration and during the phases of the menstrual cycle when estrogen and progesterone levels are higher. These protocols will examine sex hormone-effects on the osmotic stimulation of AVP and the dose-response relationship between AVP and renal water regulation. The investigators hypothesize that estrogen alone and in combination with progesterone will increase overall body water retention by increasing the AVP response to increases in plasma osmolality. In earlier studies, AVP increases during elevations in female sex hormones were not always associated with commensurate body water retention increases, so the investigators further hypothesize that estrogen interferes with AVP actions in the kidney tubule. 2) To determine effects of progesterone on renal sodium regulation. Elevations in progesterone cause a transient natriuresis, which is soon counteracted by stimulation of the renin-angiotensin-aldosterone system, as well as inhibition of atrial natriuretic peptide release from cardiac myocytes. The investigators hypothesize that progesterone will enhance sodium retention during sodium loading by attenuating the inhibition of the renin angiotensin-aldosterone system and inhibiting ANP release. These studies are important because they help clarify the effects of sex hormones on the cardiovascular system, and because symptoms related to water retention are a primary reason why 80 percent of women halt hormone therapy and fail to take advantage of its protective effects on heart, bone and brain.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/jes.0b013e31817be928
发表时间: 2008-07
期刊: Exercise and sport sciences reviews
影响因子: 5.7
作者: [Stachenfeld NS]
通讯作者: Stachenfeld NS
Exogenous oestradiol and progesterone administration does not cause oedema in healthy young women.
外源性雌二醇和黄体酮给药不会引起健康年轻女性水肿。
DOI: 10.1111/j.1365-2265.2007.02748.x
发表时间: 2007
期刊: Clinical endocrinology
影响因子: 3.2
作者: [Stachenfeld,NinaS, Taylor,HughS]
通讯作者: Taylor,HughS
Responses to a saline load in gonadotropin-releasing hormone antagonist-pretreated premenopausal women receiving progesterone or estradiol-progesterone therapy.
经促性腺激素释放激素拮抗剂预处理的绝经前妇女接受黄体酮或雌二醇-黄体酮治疗对盐水负荷的反应。
DOI: 10.1210/jc.2004-0941
发表时间: 2005
期刊: The Journal of clinical endocrinology and metabolism.
影响因子: --
作者: [Stachenfeld,NinaS, Keefe,DavidL, Taylor,HughS]
通讯作者: Taylor,HughS
Cardiometabolic effects of gender-affirming hormone therapy in transgender adolescents
  • 批准号:
    10526022
  • 项目类别:
  • 资助金额:
    $23.61万
  • 财政年份:
    2022
  • 负责人:
    NINA STACHENFELD
  • 依托单位:
Cardiometabolic effects of gender-affirming hormone therapy in transgender adolescents
  • 批准号:
    10675704
  • 项目类别:
  • 资助金额:
    $26.61万
  • 财政年份:
    2022
  • 负责人:
    NINA STACHENFELD
  • 依托单位:
Phytoestrogens, insulin resistance and endothelial function
  • 批准号:
    8174263
  • 项目类别:
  • 资助金额:
    $23.87万
  • 财政年份:
    2011
  • 负责人:
    NINA STACHENFELD
  • 依托单位:
Phytoestrogens, insulin resistance and endothelial function
  • 批准号:
    8304911
  • 项目类别:
  • 资助金额:
    $20.76万
  • 财政年份:
    2011
  • 负责人:
    NINA STACHENFELD
  • 依托单位:
海外基金